RXO Analyst Price Targets - Benzinga

RXO Inc

RXONYSE

Trade with Public

Trade with Public

$20.46

-0.25-1.21%

最終更新: Sep 30, 4:00 PM

$20.46

-0.25-1.21%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

RXO Analyst Price Targets - Benzinga

RXO Analyst Price Targets

Wall Street analyst price targets and consensus rating for RXO (RXO).

Price Target Range — 11 Quarters

Analyst Consensus — 15 Analysts

1S.Buy

5Buy

7Hold

2Sell

Consensus RatingNeutral# Analysts15Avg. Consensus PT$24Upside to Avg. PT+16.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 23, 2026	Susquehanna	Harrison Bauer	Upgrade	Negative→Neutral	$20→$19
Sep 9, 2026	Wells Fargo	Christian Wetherbee	PT Raise	Equal-Weight	$22→$23
Aug 7, 2026	UBS	Thomas Wadewitz	PT Cut	Neutral	$26→$23
Aug 7, 2026	TD Cowen	Jason Seidl	PT Cut	Sell	$19→$18
Aug 7, 2026	Citigroup	Ariel Rosa	PT Cut	Neutral	$30→$23
Aug 7, 2026	Citizens	Jeff Kauffman	Upgrade	Market Perform→Market Outperform	$30
Aug 7, 2026	Truist Securities	Lucas Servera	PT Cut	Buy	$30→$28
Jul 28, 2026	TD Cowen	Jason Seidl	Downgrade	Hold→Sell	$24→$19
Jul 16, 2026	Goldman Sachs	Jordan Alliger	PT Raise	Neutral	$18→$20
Jul 15, 2026	Truist Securities	Lucas Servera	PT Raise	Buy	$26→$30
Jul 14, 2026	Susquehanna	Bascome Majors	PT Raise	Negative	$18→$20
Jul 14, 2026	BMO Capital	Fadi Chamoun	Initiate	Outperform	$35
Jul 13, 2026	Stifel	J. Bruce Chan	PT Raise	Buy	$22→$30
Jul 9, 2026	Citigroup	Ariel Rosa	PT Raise	Neutral	$24→$30
Jun 30, 2026	UBS	Thomas Wadewitz	PT Raise	Neutral	$22→$26
Jun 26, 2026	Barclays	Brandon Oglenski	PT Raise	Overweight	$20→$28
May 15, 2026	Stifel	J. Bruce Chan	Upgrade	Hold→Buy	$22
May 8, 2026	UBS	Thomas Wadewitz	PT Raise	Neutral	$17→$22
May 8, 2026	Citigroup	Ariel Rosa	PT Raise	Neutral	$17→$24
May 8, 2026	Truist Securities	Lucas Servera	PT Raise	Buy	$20→$26

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Susquehanna Upgrades RXO to Neutral, Lowers Price Target to $19

Susquehanna analyst Harrison Bauer upgrades RXO (NYSE:RXO) from Negative to Neutral and lowers the price target from $20 to $19.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on RXO, Lowers Price Target to $23

UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $26 to $23.

Benzinga Newsdesk

PRO
TD Cowen Maintains Sell on RXO, Lowers Price Target to $17.5

TD Cowen analyst Jason Seidl maintains RXO (NYSE:RXO) with a Sell and lowers the price target from $19 to $17.5.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on RXO, Lowers Price Target to $23

Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $30 to $23.

Benzinga Newsdesk

PRO
Citizens Upgrades RXO to Market Outperform, Announces $30 Price Target

Citizens analyst Jeff Kauffman upgrades RXO (NYSE:RXO) from Market Perform to Market Outperform and announces $30 price target.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on RXO, Lowers Price Target to $28

Truist Securities analyst Lucas Servera maintains RXO (NYSE:RXO) with a Buy and lowers the price target from $30 to $28.

Benzinga Newsdesk